Bioequivalence of deflazacort and prednisone in the treatment of idiopathic nephrotic syndrome. A pilot study

Current Therapeutic Research

Volumn 54, Issue 5, 1993, Pages 588-597

  Piccoli, A ^a   Gastaldon, F ^a   Pillon, L ^a   Mussap, M ^b   Faggian, D ^b   Plebani, M ^b   Borsatti, A ^a  

^a Institute of Legal Medicine   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CLONIDINE; DEFLAZACORT; DIURETIC AGENT; FUROSEMIDE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLOMERULUS; HUMAN; IDIOPATHIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY TUBULE; MALE; MOON FACE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0027504478     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(05)80680-0     Document Type: Article

References (20)

1. Idiopathic nephrotic syndrome. Puncturing the biopsy myth
2. Steroids possessing nitrogen atoms. III. Synthesis of new highly active corticoids. 17 alfa, 16 alfa-d oxazolino steroids
3. Metabolism of deflazacort in the rat, dog and man
4. Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man
5. Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies
6. Human bioassay of corticotropin-suppressing eosinopenic and hyperglycemic potencies of deflazacort and prednisone
7. Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: A comparison with prednisone
8. Methods for reducing undesirable side effects of glucocorticoids
9. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans
10. Effects of prednisone and deflazacort on vertebral bone mass
11. Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: A comparison with prednisone
12. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man
13. Effects of glucocorticoids on calcium and phosphate excretion
14. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticosteroid therapy
15. 4 reabsorption
16. Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects
17. Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man
18. Clinical equivalence of new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and SLE patients
19. Nomogram for derivation of renal threshold phosphate concentration